These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28732827)

  • 1. The variability of respiratory symptoms and associated factors in COPD.
    Miravitlles M; Izquierdo JL; Esquinas C; Pérez M; Calle M; López-Campos JL; Rodríguez González-Moro JM; Casanova C; Esteban C; de Lucas P
    Respir Med; 2017 Aug; 129():165-172. PubMed ID: 28732827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between objectively measured physical activity and morning symptoms in COPD.
    van Buul AR; Kasteleyn MJ; Chavannes NH; Taube C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2831-2840. PubMed ID: 29042764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study.
    Miravitlles M; Worth H; Soler Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
    Respir Res; 2014 Oct; 15(1):122. PubMed ID: 25331383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: The LASSYC observational study.
    Miravitlles M; Menezes A; López Varela MV; Casas A; Ugalde L; Ramirez-Venegas A; Mendoza L; López A; Wehrmeister FC; Surmont F; Montes de Oca M
    Respir Med; 2018 Jan; 134():62-69. PubMed ID: 29413510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease.
    Stephenson JJ; Cai Q; Mocarski M; Tan H; Doshi JA; Sullivan SD
    Int J Chron Obstruct Pulmon Dis; 2015; 10():577-86. PubMed ID: 25844033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
    Hareendran A; Make BJ; Zaiser E; Garcia Gil E
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1633-1645. PubMed ID: 29849455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the psychometric properties of the Nighttime Symptoms of COPD Instrument.
    Mocarski M; Zaiser E; Trundell D; Make BJ; Hareendran A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():475-87. PubMed ID: 25834415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom variability in patients with severe COPD: a pan-European cross-sectional study.
    Kessler R; Partridge MR; Miravitlles M; Cazzola M; Vogelmeier C; Leynaud D; Ostinelli J
    Eur Respir J; 2011 Feb; 37(2):264-72. PubMed ID: 21115606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD.
    Ding B; Small M; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():589-599. PubMed ID: 28243077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of night-time symptoms in COPD: a real-world study in five European countries.
    Price D; Small M; Milligan G; Higgins V; Gil EG; Estruch J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():595-603. PubMed ID: 24348032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily Symptom Variability in Patients With Stable COPD: A Narrative Review.
    Wu M; Wang Z; Li M; Li K
    West J Nurs Res; 2018 Oct; 40(10):1543-1561. PubMed ID: 28459177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cross-Sectional Study in Patients with Severe COPD to Assess the Perception of Symptom Variability (COPVAR) in the Middle East and Africa.
    Kokturk N; Abuharbid W; Albanna AS; Gunen H; Gurgun A; Khadadah M; Malvolti E; Soliman M; van Zyl-Smit R; Zidouni N; Alzaabi A
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2959-2970. PubMed ID: 31908444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study.
    Scichilone N; Antonelli Incalzi R; Blasi F; Schino P; Cuttitta G; Zullo A; Ori A; Canonica GW;
    BMC Pulm Med; 2019 Sep; 19(1):171. PubMed ID: 31500607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study.
    Kuyucu T; Güçlü SZ; Saylan B; Demir C; Senol T; Güner S; Koyuncu E; Ozen F; Oztürk S; Cangül Z; Ağanoğlu S; Ozkaya S; Ocak SC; Akkurt H; Intepe YS; Bayrak MG; Güler T; Bekçi TT; Soyyiğit S; Seyfettin S; Kula O; Akbay MO; Büyükgöze B; Asal G; Başlilar S; Oztürk O;
    Tuberk Toraks; 2011; 59(4):328-39. PubMed ID: 22233302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease severity and symptoms among patients receiving monotherapy for COPD.
    Dransfield MT; Bailey W; Crater G; Emmett A; O'Dell DM; Yawn B
    Prim Care Respir J; 2011 Mar; 20(1):46-53. PubMed ID: 20886200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.
    Soler-Cataluña JJ; Sauleda J; Valdés L; Marín P; Agüero R; Pérez M; Miravitlles M
    Arch Bronconeumol; 2016 Jun; 52(6):308-15. PubMed ID: 26774700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
    Marin JM; Beeh KM; Clemens A; Castellani W; Schaper L; Saralaya D; Gunstone A; Casamor R; Kostikas K; Aalamian-Mattheis M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1425-34. PubMed ID: 27418815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation.
    Uccelli S; Pini L; Bottone D; Ranieri P; Orzes N; Tantucci C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2549-2558. PubMed ID: 33116471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.